WDNA vs. FHLC
WDNA (WisdomTree BioRevolution Fund) and FHLC (Fidelity MSCI Health Care Index ETF) are both Health & Biotech Equities funds - WDNA tracks the WisdomTree BioRevolution Index while FHLC tracks the MSCI USA IMI Health Care Index. Both are passively managed. Over the past 5 years, WDNA returned -5.33%/yr vs 4.50%/yr for FHLC. A 0.70 correlation means they provide meaningful diversification when combined. WDNA charges 0.45%/yr vs 0.08%/yr for FHLC.
Performance
WDNA vs. FHLC - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, WDNA achieves a 5.85% return, which is significantly higher than FHLC's -3.90% return.
WDNA
- 1D
- 1.24%
- 1M
- -0.73%
- YTD
- 5.85%
- 6M
- 8.14%
- 1Y
- 45.86%
- 3Y*
- 2.45%
- 5Y*
- -5.33%
- 10Y*
- —
FHLC
- 1D
- 0.82%
- 1M
- 1.50%
- YTD
- -3.90%
- 6M
- -4.11%
- 1Y
- 14.43%
- 3Y*
- 6.14%
- 5Y*
- 4.50%
- 10Y*
- 9.14%
WDNA vs. FHLC - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
WDNA WisdomTree BioRevolution Fund | 5.85% | 22.68% | -14.18% | -2.07% | -26.29% | -5.27% |
FHLC Fidelity MSCI Health Care Index ETF | -3.90% | 15.42% | 2.48% | 2.58% | -5.55% | 13.66% |
Correlation
The correlation between WDNA and FHLC is 0.64, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.64 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.64 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.70 |
Correlation (All Time) Calculated using the full available price history since Jun 4, 2021 | 0.70 |
The correlation between WDNA and FHLC has been stable across timeframes, ranging from 0.64 to 0.70 - a consistent structural relationship.
WDNA vs. FHLC - Sectors Allocation Comparison
Sectors
WDNA
FHLC
Healthcare
Basic Materials
-
Consumer Defensive
-
Energy
-
Communication Services
-
-
Consumer Cyclical
-
-
Financial Services
-
Industrials
-
Real Estate
-
-
Technology
-
Utilities
-
-
Healthcare
WDNA
FHLC
Basic Materials
WDNA
FHLC
-
Consumer Defensive
WDNA
FHLC
-
Energy
WDNA
FHLC
-
Communication Services
WDNA
-
FHLC
-
Consumer Cyclical
WDNA
-
FHLC
-
Financial Services
WDNA
-
FHLC
Industrials
WDNA
-
FHLC
Real Estate
WDNA
-
FHLC
-
Technology
WDNA
-
FHLC
Utilities
WDNA
-
FHLC
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
WDNA vs. FHLC — Risk / Return Rank
WDNA
FHLC
WDNA vs. FHLC - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for WisdomTree BioRevolution Fund (WDNA) and Fidelity MSCI Health Care Index ETF (FHLC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| WDNA | FHLC | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.79 | ||
| Sortino ratioReturn per unit of downside risk | +1.06 | ||
| Omega ratioGain probability vs. loss probability | 1.30 | 1.18 | +0.12 |
| Calmar ratioReturn relative to maximum drawdown | 3.94 | 1.40 | +2.54 |
| Martin ratioReturn relative to average drawdown | 8.95 | 3.52 | +5.43 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| WDNA | FHLC | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.81 | 1.01 | +0.79 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.21 | 0.30 | -0.52 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | 0.55 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.21 | 0.61 | -0.82 |
Drawdowns
WDNA vs. FHLC - Drawdown Comparison
The maximum WDNA drawdown since its inception was -58.87%, which is greater than FHLC's maximum drawdown of -28.76%. Use the drawdown chart below to compare losses from any high point for WDNA and FHLC.
Loading charts...
Drawdown Indicators
| WDNA | FHLC | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -58.87% | -28.76% | -30.11% |
Max Drawdown (1Y)Largest decline over 1 year | -11.70% | -10.38% | -1.32% |
Max Drawdown (3Y)Largest decline over 3 years | -38.25% | -16.87% | -21.38% |
Max Drawdown (5Y)Largest decline over 5 years | -58.87% | -17.73% | -41.14% |
Max Drawdown (10Y)Largest decline over 10 years | — | -28.76% | — |
Current DrawdownCurrent decline from peak | -31.86% | -6.96% | -24.90% |
Average DrawdownAverage peak-to-trough decline | -35.65% | -5.19% | -30.46% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 5.14% | 4.11% | +1.03% |
Volatility
WDNA vs. FHLC - Volatility Comparison
WisdomTree BioRevolution Fund (WDNA) has a higher volatility of 6.75% compared to Fidelity MSCI Health Care Index ETF (FHLC) at 4.05%. This indicates that WDNA's price experiences larger fluctuations and is considered to be riskier than FHLC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| WDNA | FHLC | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.75% | 4.05% | +2.70% |
Volatility (6M)Calculated over the trailing 6-month period | 16.39% | 10.11% | +6.28% |
Volatility (1Y)Calculated over the trailing 1-year period | 25.53% | 14.33% | +11.20% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 25.04% | 14.97% | +10.07% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 25.04% | 16.81% | +8.23% |
WDNA vs. FHLC - Expense Ratio Comparison
WDNA has a 0.45% expense ratio, which is higher than FHLC's 0.08% expense ratio.
Dividends
WDNA vs. FHLC - Dividend Comparison
WDNA's dividend yield for the trailing twelve months is around 4.31%, more than FHLC's 1.43% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
FHLC Fidelity MSCI Health Care Index ETF | 1.43% | 1.40% | 1.51% | 1.40% | 1.30% | 1.16% | 1.45% | 1.18% | 1.38% | 1.38% | 1.40% | 2.07% |
WDNA WisdomTree BioRevolution Fund | 4.31% | 4.57% | 0.75% | 0.80% | 0.38% | 0.10% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
WDNA and FHLC have a correlation of 0.64, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
WDNA has higher volatility (6.75%) compared to FHLC (4.05%). In terms of maximum drawdown, WDNA dropped -58.87% vs FHLC's -28.76%.
On 5-year performance, FHLC leads with 4.50% vs -5.33% for WDNA. On fees, FHLC is cheaper at 0.08% per year. On volatility, FHLC has been the lower-risk option at 4.05%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 5-year period, FHLC has performed better with a 4.50% return vs -5.33%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
FHLC is cheaper with a 0.08% expense ratio, compared with 0.45% for WDNA.
WDNA has the higher dividend yield at 4.31%, compared with 1.43% for FHLC.
WDNA tracks WisdomTree BioRevolution Index, while FHLC tracks MSCI USA IMI Health Care Index. They also come from different issuers: WisdomTree and Fidelity. Their fees differ too: 0.45% for WDNA and 0.08% for FHLC.
WDNA currently has the higher Sharpe Ratio (1.81 vs 1.01), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for WDNA and FHLC
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer